WaferGen Biosystems, Inc. (WGBS.OB) to Use $7.2M Registered Direct Offering to Supercharge SmartChip Roll Out
WaferGen Biosystems, Inc., www.wafergen.com – a pioneer in analytical systems which utilize emerging gene expression, genotyping and stem cell/cell biology research for biopharma and life science market applications, closed a $7.2M registered direct offering yesterday. The Company has struck gold with what it believes will be rapidly adopted as the platform of choice for future genetic analysis and cell monitoring, because the SmartChip™ Real-Time PCR system is the first of its kind to offer unprecedented performance capabilities unmatched by existing technologies. The SmartChip combines unmatched throughput with the cost-effectiveness of microarray applications, and the high-fidelity, accuracy and sensitivity of real-time…